lidoflazine has been researched along with Bradycardia in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Bradycardia: Cardiac arrhythmias that are characterized by excessively slow HEART RATE, usually below 50 beats per minute in human adults. They can be classified broadly into SINOATRIAL NODE dysfunction and ATRIOVENTRICULAR BLOCK.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Széplaki, S | 1 |
| Széplaki, Z | 1 |
1 other study available for lidoflazine and Bradycardia
| Article | Year |
|---|---|
[Fludilat treatment of vagotonic and subendocardial disturbances of cardiac metabolism and bradycardiac coronary diseases (author's transl)].
Topics: Acute Disease; Adult; Aged; Bencyclane; Bradycardia; Chronic Disease; Coronary Circulation; Coronary | 1976 |